NCT06984250View on ClinicalTrials.gov

Hypofractionated Radiotherapy With Concomitant Tumor Bed Boost for Breast Cancer

RecruitingOBSERVATIONAL
Enrollment

315

Participants

Timeline

Start Date

February 6, 2025

Primary Completion Date

February 28, 2027

Study Completion Date

February 28, 2030

Conditions
Early Breast CancerDuctal Breast Carcinoma In Situ
Interventions
RADIATION

Hypofractionated Radiation Therapy

Hypofractionated breast radiotherapy (HFRT) with hybrid techniques combining field-in-field intensity-modulated RT (FIF-IMRT) to the whole breast with inverse-IMRT for concomitant boost

Trial Locations (2)

100

NOT_YET_RECRUITING

National Taiwan University Hospital, Taipei

632

RECRUITING

National Taiwan University Hospital Yunlin Branch, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER